Mark Bustoros
12PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jun 09, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur
|Jan 03, 2025
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.Omar Nadeem, Michelle P Aranha, Robert Redd
|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz
|Feb 14, 2023
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia.Mateo Mejia Saldarriaga, Mohammad Alhomoud, Gail Roboz
|Jun 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis
|Dec 04, 2021
Regular Aspirin Use and Mortality in Patients with Multiple Myeloma.Catherine R Marinac, Dong Hoon Lee, Graham A Colditz
Pageof 2
Frequent Collaborators
5 joint publications
Irene M Ghobrial
3 joint publications
Robert Redd
2 joint publications
P Leif Bergsagel
2 joint publications
Shaji Kumar
2 joint publications
Jens Hillengass
2 joint publications
Gad Getz
2 joint publications
Brian A Walker
2 joint publications
Chia-Jen Liu
2 joint publications
Jonathan J Keats
2 joint publications
Tarek H Mouhieddine
